|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 114, Issue 4 853-860, Copyright © 1992 by Company of Biologists
JOURNAL ARTICLES |
JH Miner, JB Miller and BJ Wold
Division of Biology, California Institute of Technology, Pasadena 91125.
Forced expression of the myogenic regulatory gene MyoD in many types of cultured cells initiates their conversion into skeletal muscle. It is not known, however, if MyoD expression serves to activate all or part of the skeletal muscle program in vivo during animal development, nor is it known how limiting the influences of cellular environment may be on the regulatory effects of MyoD. To begin to address these issues, we have produced transgenic mice which express MyoD in developing heart, where neither MyoD nor its three close relatives--myogenin, Myf-5, and MRF4/herculin/Myf-6--are normally expressed. The resulting gross phenotype in offspring from multiple, independent transgenic founders includes abnormal heart morphology and ultimately leads to death. At the molecular level, affected hearts exhibit activation of skeletal muscle-specific regulatory as well as structural genes. We conclude that MyoD is able to initiate the program that leads to skeletal muscle differentiation during mouse development, even in the presence of the ongoing cardiac differentiation program. Thus, targeted misexpression of this tissue-specific regulator during mammalian embryogenesis can activate, either directly or indirectly, a diverse set of genes normally restricted to a different cell lineage and a different cellular environment.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  X. Long, E. E. Creemers, D.-Z. Wang, E. N. Olson, and J. M. Miano Myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation PNAS, October 16, 2007; 104(42): 16570 - 16575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fukushige and M. Krause The myogenic potency of HLH-1 reveals wide-spread developmental plasticity in early C. elegans embryos Development, April 15, 2005; 132(8): 1795 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Delfini and D. Duprez Ectopic Myf5 or MyoD prevents the neuronal differentiation program in addition to inducing skeletal muscle differentiation, in the chick neural tube Development, February 15, 2004; 131(4): 713 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Sarnat Molecular Genetic Classification of Central Nervous System Malformations J Child Neurol, October 1, 2000; 15(10): 675 - 687. [Abstract] [PDF]
|
|
|
|
|
|
M Delfini, E Hirsinger, O Pourquie, and D Duprez Delta 1-activated notch inhibits muscle differentiation without affecting Myf5 and Pax3 expression in chick limb myogenesis Development, January 12, 2000; 127(23): 5213 - 5224. [Abstract] [PDF]
|
|
|
|
|
|
B Kablar, S Tajbakhsh, and M. Rudnicki Transdifferentiation of esophageal smooth to skeletal muscle is myogenic bHLH factor-dependent Development, January 4, 2000; 127(8): 1627 - 1639. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Menard, S. Pupier, D. Mornet, M. Kitzmann, J. Nargeot, and P. Lory Modulation of L-type Calcium Channel Expression during Retinoic Acid-induced Differentiation of H9C2 Cardiac Cells J. Biol. Chem., October 8, 1999; 274(41): 29063 - 29070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Alyonycheva, L. Cohen-Gould, C. Siewert, D. A. Fischman, and T. Mikawa Skeletal Muscle–Specific Myosin Binding Protein-H Is Expressed in Purkinje Fibers of the Cardiac Conduction System Circ. Res., May 19, 1997; 80(5): 665 - 672. [Abstract] [Full Text]
|
|
|
|
|
|
R. Kelly and M. Buckingham Manipulating Myosin Light Chain 2 Isoforms In Vivo : A Transgenic Approach to Understanding Contractile Protein Diversity Circ. Res., May 19, 1997; 80(5): 751 - 753. [Full Text]
|
|
|
|
|
|
J.G. Edwards, G.E. Lyons, B.K. Micales, A. Malhotra, S. Factor, and L.A. Leinwand Cardiomyopathy in Transgenic myf5 Mice Circ. Res., March 1, 1996; 78(3): 379 - 387. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. D. Becker, K. R. Gottshall, and K. R. Chien Strategies for Studying Cardiovascular Phenotypes in Genetically Manipulated Mice Hypertension, March 1, 1996; 27(3): 495 - 501. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Patapoutian, B. J. Wold, and R. A. Wagner Evidence for Developmentally Programmed Transdifferentiation in Mouse Esophageal Muscle Science, December 15, 1995; 270(5243): 1818 - 1821. [Abstract] [PDF]
|
|
|
|
|
|
S Tajbakhsh and M. Buckingham Lineage restriction of the myogenic conversion factor myf-5 in the brain Development, January 12, 1995; 121(12): 4077 - 4083. [Abstract] [PDF]
|
|
|
|
|
|
A Patapoutian, J. Yoon, J. Miner, S Wang, K Stark, and B Wold Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome Development, January 10, 1995; 121(10): 3347 - 3358. [Abstract] [PDF]
|
|
|
|
 |
|
 R A Rupp, L Snider, and H Weintraub Xenopus embryos regulate the nuclear localization of XMyoD. Genes & Dev., June 1, 1994; 8(11): 1311 - 1323. [Abstract] [PDF]
|
|
|
|
|
|
A Patapoutian, J. Miner, G. Lyons, and B Wold Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice Development, January 5, 1993; 118(1): 61 - 69. [Abstract] [PDF]
|
|
|
|
|
|
T. Smith, N. Block, S. Rhodes, S. Konieczny, and J. Miller A unique pattern of expression of the four muscle regulatory factor proteins distinguishes somitic from embryonic, fetal and newborn mouse myogenic cells Development, January 3, 1993; 117(3): 1125 - 1133. [Abstract] [PDF]
|
|
|
|
 |
|
 J.R. Sanes, M.J. Donoghue, M.C. Wallace, and J.P. Merlie Rostrocaudal Differences among Muscles Revealed by a Transgene: Graded Expression at Low Copy Number Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 451 - 460. [Abstract] [PDF]
|
|
